The ERCC4 gene, also known as XPF, plays a crucial role in the DNA repair process, particularly in nucleotide excision repair (NER). Mutations in this gene are associated with Xeroderma Pigmentosum (XP) group F, a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) rays from sunlight, leading to an increased risk of skin cancers and premature skin aging. Individuals with Xeroderma Pigmentosum group F may also experience neurological abnormalities.
The ERCC4 Gene Xeroderma Pigmentosum Group F Genetic Test is a specialized diagnostic tool used to identify mutations in the ERCC4 gene. This test is crucial for confirming a diagnosis of Xeroderma Pigmentosum group F, enabling early intervention and management of the condition. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory for the presence of mutations in the ERCC4 gene.
This genetic test is available at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the ERCC4 Gene Xeroderma Pigmentosum Group F Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and specificity of this test, it provides invaluable information for affected individuals and their families, allowing for better-informed decisions regarding treatment, management, and genetic counseling.
The ERCC5 Gene Xeroderma Pigmentosum Group G Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ERCC5 gene. These mutations are associated with Xeroderma Pigmentosum Group G, a rare genetic condition characterized by extreme sensitivity to ultraviolet (UV) rays from sunlight, leading to a higher risk of skin cancers and premature skin aging. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic abnormalities in the ERCC5 gene, which plays a crucial role in DNA repair mechanisms. Early detection through this test can be pivotal in managing the condition, enabling personalized preventive measures and treatments to mitigate the effects of the disorder. DNA Labs UAE offers this test as part of its comprehensive suite of genetic testing services, employing advanced technologies to ensure accurate and reliable results.
The "POLH Gene Xeroderma Pigmentosum Variant Type Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the POLH gene, which are associated with the variant type of Xeroderma Pigmentosum (XP-V). Xeroderma Pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) rays from sunlight, leading to a higher risk of skin cancers and premature skin aging. The variant type, specifically linked to mutations in the POLH gene, involves defects in the DNA polymerase eta, crucial for the effective repair of UV-induced DNA damage.
This genetic test is crucial for individuals suspected of having XP-V, offering them a definitive diagnosis. Early identification of the condition can lead to preventive measures against UV exposure, thus significantly reducing the risk of skin cancers and improving quality of life. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for mutations in the POLH gene.
DNA Labs UAE offers this comprehensive genetic testing service for 4400 AED, providing individuals and families with essential information for managing and understanding the implications of Xeroderma Pigmentosum Variant Type. The cost reflects the intricate processes involved in genetic analysis and the invaluable insights it provides into managing this rare condition.
The ERCC4 Gene XFE Progeroid Syndrome Genetic Test is a specialized diagnostic tool used to detect mutations in the ERCC4 gene, which are associated with XFE Progeroid Syndrome - a rare genetic disorder characterized by accelerated aging and various developmental anomalies. The syndrome is part of a group of conditions known as progeroid syndromes, which mimic aspects of physiological aging at an early age, leading to a range of health issues including growth delays, skin abnormalities, and, in some cases, increased cancer risk.
This genetic test involves analyzing the DNA to identify mutations in the ERCC4 gene, providing crucial information for the diagnosis, management, and potential treatment plans for affected individuals. Early detection through genetic testing can play a significant role in managing the symptoms and improving the quality of life for those with XFE Progeroid Syndrome.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the ERCC4 Gene XFE Progeroid Syndrome Genetic Test is set at 4400 AED, reflecting the specialized nature of the test and the comprehensive analysis it entails. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality standards to ensure accurate and reliable results, offering support to patients and families navigating the complexities of genetic disorders.
The "FOXF1 Gene Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACD/MPV) Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the FOXF1 gene. These mutations are known to cause Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACD/MPV), a rare and life-threatening congenital disorder. This condition affects the development of the lungs, particularly the alveoli and capillaries, leading to severe respiratory distress shortly after birth. Additionally, ACD/MPV is characterized by the misalignment of pulmonary veins, which can complicate the heart's ability to circulate oxygenated blood effectively.
The genetic test involves analyzing the patient's DNA to identify any abnormalities in the FOXF1 gene, which plays a critical role in lung and blood vessel development. Early and accurate diagnosis through this test can provide essential information for the management of the condition, although there is currently no cure for ACD/MPV. The cost of the test at DNA Labs UAE is 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used to detect these genetic mutations. Families who are at risk or have a history of ACD/MPV may consider this test for early diagnosis and potential management strategies for affected infants.
The FLNA Gene Terminal Osseous Dysplasia Genetic Test is a specialized diagnostic tool designed to detect mutations in the FLNA gene, which are implicated in the development of Terminal Osseous Dysplasia (TOD). This condition is a rare genetic disorder characterized by skeletal abnormalities, digital anomalies, and skin pigmentation defects. The test involves analyzing the patient's DNA to identify any genetic variations in the FLNA gene that could lead to the manifestation of TOD.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers a crucial insight for families affected by or at risk of TOD. Understanding the genetic makeup of an individual with respect to the FLNA gene can aid in early diagnosis, management, and intervention strategies, potentially improving the quality of life for those affected.
The cost of the FLNA Gene Terminal Osseous Dysplasia Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expertise required to accurately detect and interpret mutations in the FLNA gene. For families and individuals considering this test, it represents a significant step towards obtaining a clear diagnosis and understanding the genetic underpinnings of Terminal Osseous Dysplasia.
The THSD1 Gene Thrombospondin Type 1 Domain-Containing Protein 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to analyze the THSD1 gene, which is known for its role in encoding a protein involved in cellular processes such as cell adhesion and migration. Mutations in the THSD1 gene have been linked to various medical conditions, making this test a crucial element in the diagnosis and management of diseases associated with the gene. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results. By identifying specific genetic alterations in the THSD1 gene, healthcare professionals can better understand the condition of a patient and tailor personalized treatment plans, thereby improving patient outcomes.
The DLX3 Gene Trichodontoosseous Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the DLX3 gene, which are known to cause Trichodontoosseous Syndrome (TDO). TDO is a rare genetic condition characterized by distinctive dental abnormalities, bone density issues, and hair texture changes. The DLX3 gene plays a crucial role in the development of teeth, bones, and hair, making its mutation a key indicator of TDO.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis for individuals suspected of having TDO or for those carrying a family history of the condition. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the DLX3 gene.
The cost of the DLX3 Gene Trichodontoosseous Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the advanced technology and expertise required to accurately identify the genetic variations associated with the syndrome. Upon completion, the test results can offer crucial information for the diagnosis, management, and understanding of Trichodontoosseous Syndrome, aiding healthcare providers in developing a tailored approach to treatment and care for affected individuals.
The SKIV2L Gene Trichohepatoenteric Syndrome Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the SKIV2L gene. These mutations are responsible for causing Trichohepatoenteric Syndrome Type 2, a rare genetic disorder characterized by chronic diarrhea, liver disease, facial dysmorphism, and woolly hair. The test is crucial for early diagnosis and management of the condition, providing essential information for tailored treatment plans and genetic counseling. Priced at 4400 AED, this test is a valuable resource for families and individuals at risk, offering insights into this rare genetic syndrome and facilitating appropriate medical interventions.
The TRPS1 gene trichorhinophalangeal syndrome type 1 genetic test is a specialized diagnostic tool aimed at detecting mutations in the TRPS1 gene, which are responsible for trichorhinophalangeal syndrome type 1 (TRPS1). This condition is characterized by distinctive craniofacial and skeletal abnormalities, including sparse scalp hair, a bulbous nose, long flat philtrum, thin upper lip, cone-shaped epiphyses, and short stature. The genetic test involves analyzing the patient's DNA to identify any alterations in the TRPS1 gene that might lead to the syndrome.
Administered at DNA Labs UAE, a leading facility in genetic diagnostics, this test is crucial for accurate diagnosis, allowing for proper management and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results accurately. This test is particularly important for individuals showing symptoms of the syndrome or those with a family history of TRPS1, as early diagnosis can significantly improve the quality of life through tailored treatment and intervention strategies.
